This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Mississippi State University, Texas A&M University System. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Ravichandran Akshaya: Innovator in Cancer Treatment
Introduction
Ravichandran Akshaya is a notable inventor based in Bryan, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of proliferative disorders such as cancer. His innovative work has led to the development of unique formulations that hold promise for improving patient outcomes.
Latest Patents
Ravichandran Akshaya holds a patent for "Occidiofungin formations and uses thereof." This patent discloses occidiofungin formulations and their applications for treating proliferative disorders. The methods of producing these formulations are also detailed, along with techniques for treating subjects using the formulations. The formulations may include occidiofungin combined with one or more cyclodextrins, and they may optionally contain additional chemotherapeutic agents, lipid vesicles, and/or aqueous solvents, including pharmaceutically acceptable buffers and excipients.
Career Highlights
Throughout his career, Ravichandran has worked with esteemed institutions such as Mississippi State University and The Texas A&M University System. His experience in these organizations has allowed him to collaborate with other professionals and contribute to groundbreaking research in his field.
Collaborations
Ravichandran has collaborated with notable colleagues, including James Leif Smith and Stephen B Pruett. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Ravichandran Akshaya's innovative work in developing occidiofungin formulations represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile